Sam Herron

ID: 1b83b8f7-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

FDA Approves Extended Dosing Interval for Regeneron’s EYLEA HD (aflibercept)

Big Molecule Watch · April 14, 2026

Formycon Announces New Dupilumab Biosimilar Candidate

Big Molecule Watch · November 25, 2025

Factor Bioscience Sues Cellectis and AstraZeneca Alleging Infringement of Gene-Editing Patents

Big Molecule Watch · September 26, 2025

European Commission Approves Moderna’s Updated COVID-19 Vaccine

Big Molecule Watch · August 18, 2025

EMA Issues Positive CHMP Opinions for Fresenius Denosumab Biosimilars

Big Molecule Watch · June 2, 2025